These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11267938)

  • 41. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
    Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
    Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
    Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
    Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Gorgoulis VG; Zacharatos P; Kotsinas A; Mariatos G; Liloglou T; Vogiatzi T; Foukas P; Rassidakis G; Garinis G; Ioannides T; Zoumpourlis V; Bramis J; Michail PO; Asimacopoulos PJ; Field JK; Kittas C
    Mol Med; 2000 Mar; 6(3):208-37. PubMed ID: 10965496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China.
    Yang G; Zhang Z; Liao J; Seril D; Wang L; Goldstein S; Yang CS
    Int J Cancer; 1997 Sep; 72(5):746-51. PubMed ID: 9311588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The expression of Mdm2 protein and p53 mutation in lung squamous cell carcinomas and their clinicopathological significance].
    Zhang J; Liu H; Li S; Gu C
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):163-5. PubMed ID: 11812371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.
    Droller MJ
    J Urol; 2001 May; 165(5):1811-2. PubMed ID: 11345951
    [No Abstract]   [Full Text] [Related]  

  • 52. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma.
    Liu CJ; Chang KW; Chao SY; Kwan PC; Chang SM; Yen RY; Wang CY; Wong YK
    J Oral Pathol Med; 2004 Jul; 33(6):327-34. PubMed ID: 15200480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
    Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma.
    Matsumoto M; Natsugoe S; Nakashima S; Okumura H; Sakita H; Baba M; Takao S; Aikou T
    Ann Surg Oncol; 2001 Aug; 8(7):598-604. PubMed ID: 11508622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
    Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
    Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p53, pRb, p16 and proliferating cell nuclear antigen in squamous cell carcinomas arising on a giant porokeratosis.
    Chang SE; Lim Y; Lee H; Choi J; Sung K
    Br J Dermatol; 1999 Sep; 141(3):575-6. PubMed ID: 10583074
    [No Abstract]   [Full Text] [Related]  

  • 58. p53, mdm-2, and p21 waf-1 in the porokeratoses.
    Nelson C; Cowper S; Morgan M
    Am J Dermatopathol; 1999 Oct; 21(5):420-5. PubMed ID: 10535569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
    Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.
    Sanchez E; Chacon I; Plaza MM; Muñoz E; Cruz MA; Martinez B; Lopez L; Martinez-Montero JC; Orradre JL; Saez AI; Garcia JF; Piris MA
    J Clin Oncol; 1998 May; 16(5):1931-9. PubMed ID: 9586912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.